-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Monopar Therapeutics, Maintains $104 Price Target

Benzinga·02/23/2026 12:55:52
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Monopar Therapeutics (NASDAQ:MNPR) with a Buy and maintains $104 price target.